WOBURN, Mass., March 10, 2025 (GLOBE NEWSWIRE) -- Abpro Holdings, Inc. (Nasdaq:ABP) ("Abpro"), a biotechnology company dedicated to advancing next-generation antibody therapies for severe and ...
Abpro Holdings (ABP) announced the departure of CEO Ian Chan. Commenting on the leadership change, Abpro Board Chairman and CEO Miles Suk, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback